Celularity Inc (CELU)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $20.45M
Last updated: Nov 17, 2026 at 11:03 AM ET
Celularity Inc (CELU) Competitors
The companies most similar to Celularity are Pluri (PLUR), CEL-SCI (CVM) and NextCure (NXTC). By market cap, Celularity ranks 8th of the 13 companies on this page; Telomir Pharmaceuticals, Inc. Common Stock (TELO) is the largest at $36.15M.
Peer Comparison
CELU's revenue growth of -5.3% is above the peer median of -27.8%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Celularity (CELU) | $20.45M | N/A | 1.0x | -245.7% | N/A | -5.3% | 0.00% |
| Pluri Inc. (PLUR) | $15.09M | N/A | 8.7x | 0.0% | -650.8% | -15.8% | 0.00% |
| CEL-SCI Corp (CVM) | $22.51M | N/A | N/A | 0.0% | -109.0% | -62.7% | 0.00% |
| NextCure Inc (NXTC) | $29.31M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Collplant Biotechnologies Ltd (CLGN) | $14.27M | N/A | 21.0x | 0.0% | N/A | -39.7% | 0.00% |
| Estrella Immunopharma Inc. (ESLA) | $22.36M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | $36.15M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Briacell Therapeutics Corp (BCTX) | $29.60M | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | $9.90M | N/A | 16.4x | 0.0% | -72.3% | -15.9% | 0.00% |
| Cyclerion Therapeutics Inc (CYCN) | $15.73M | N/A | N/A | 0.0% | N/A | -43.2% | 0.00% |
| INmune Bio Inc (INMB) | $32.51M | N/A | N/A | 0.0% | N/A | 257.1% | 0.00% |
| CervoMed Inc. (CRVO) | $25.57M | N/A | N/A | 0.0% | N/A | -99.6% | 0.00% |
| Biocardia Inc (BCDA) | $12.58M | N/A | N/A | 0.0% | N/A | -100.0% | 0.00% |
| Peer median | $22.44M | N/A | 16.4x | 0.0% | -109.0% | -27.8% | 0.00% |
Similar Companies
These are the 12 companies most similar to Celularity, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Pluri Inc. (PLUR) | Pluri Inc. is an innovative biotechnology company at the forefront of regenerative medicine and immunotherapy... | PLUR competitors |
| CEL-SCI Corp (CVM) | CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. | CVM competitors |
| NextCure Inc (NXTC) | NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other... | NXTC competitors |
| Collplant Biotechnologies Ltd (CLGN) | CollPlant Biotechnologies Ltd., an aesthetic and regenerative medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs... | CLGN competitors |
| Estrella Immunopharma Inc. (ESLA) | Estrella Immunopharma, Inc., a preclinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. | ESLA competitors |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO) | Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human... | TELO competitors |
| Briacell Therapeutics Corp (BCTX) | BriaCell Therapeutics Corp. The company is headquartered in West Vancouver, Canada. | BCTX competitors |
| CytoMed Therapeutics Limited Ordinary Shares (GDTC) | CytoMed Therapeutics Limited, a pre-clinical biopharmaceutical company, focuses on developing novel cell-based immunotherapies for the treatment of human... | |
| Cyclerion Therapeutics Inc (CYCN) | Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery, development... | |
| INmune Bio Inc (INMB) | INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on reprogramming the patient's innate immune system to treat cancer, Alzheimer's disease... | INMB competitors |
| CervoMed Inc. (CRVO) | CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of drug treatments for neurodegenerative diseases. | CRVO competitors |
| Biocardia Inc (BCDA) | BioCardia, Inc., a clinical-stage regenerative medicine company, develops therapies for cardiovascular disease. | BCDA competitors |
Frequently Asked Questions About CELU
Who are Celularity's main competitors?
The companies most similar to Celularity include Pluri (PLUR), CEL-SCI (CVM), NextCure (NXTC), Collplant Biotechnologies (CLGN) and Estrella Immunopharma (ESLA), listed from the closest match.
Who is Celularity's biggest competitor?
Telomir Pharmaceuticals, Inc. Common Stock (TELO) is the largest of the similar companies at $36.15M; Pluri (PLUR) is the closest match by business profile, size, sector and industry.
How does CELU stock compare with its competitors?
CELU's P/S is 1.0x against a peer median of 16.4x; its net margin is -245.7% against a peer median of 0.0%.
Which of Celularity's competitors pays a higher dividend?
Celularity pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Celularity bigger than its competitors?
No. Celularity is 8th by market cap among the 13 companies on this page; the largest is Telomir Pharmaceuticals, Inc. Common Stock (TELO) at $36.15M.
CELU pages: Overview, Earnings, Financials, Competitors